2CB-2-EtO
Pharmaceutical compound
From Wikipedia, the free encyclopedia
2CB-2-EtO, also known as 4-bromo-2-methoxy-5-ethoxyphenethylamine, is a psychedelic drug of the phenethylamine, 2C, and TWEETIO families related to 2C-B.[1][2][3][4] It is the derivative of 2C-B in which the methoxy group at the 2 position has been replaced with an ethoxy group.[1][2][3][4]
- None
| Clinical data | |
|---|---|
| Other names | 2C-B-2-ETO; 4-Bromo-5-ethoxy-2-methoxyphenethylamine; 2-Methoxy-4-bromo-5-ethoxyphenethylamine |
| Routes of administration | Oral[1] |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | 3–6 hours[1] |
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C11H16BrNO2 |
| Molar mass | 274.158 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
According to Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, 2CB-2-EtO produces maximal effects at a dose of about 15 mg orally.[1][3][4] Higher doses of 30 to 50 mg orally did not increase its effects any further but only prolonged their duration, from about 3 hours to perhaps 6 hours.[1][3][4] 2CB-2-EtO was said to have not had an intensity that resembled that of 2C-B at any dose.[1] It was also said to be dramatically or about 5-fold less potent than 2C-B.[2] Beyond the preceding, the specific effects of 2CB-2-EtO were not described.[1][2][3][4]
The chemical synthesis of 2CB-2-EtO has been described.[1]
2CB-2-EtO was first described in the literature by Shulgin in PiHKAL in 1991.[1] It was developed and tested by Darrell Lemaire, with publication via personal communication with Shulgin.[3][5][6][7][8] The drug is a controlled substance in Canada under phenethylamine blanket-ban language.[9]
See also
- TWEETIO (psychedelics)
- 2CD-5EtO
- 2CB-5PrO (ASR-2001)